It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMRX’s FA Score shows that 1 FA rating(s) are green whileEBS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMRX’s TA Score shows that 4 TA indicator(s) are bullish while EBS’s TA Score has 5 bullish TA indicator(s).
AMRX (@Pharmaceuticals: Other) experienced а -5.74% price change this week, while EBS (@Pharmaceuticals: Other) price change was -15.18% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.28%. For the same industry, the average monthly price growth was -2.37%, and the average quarterly price growth was +50.06%.
AMRX is expected to report earnings on May 02, 2025.
EBS is expected to report earnings on Apr 24, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
AMRX | EBS | AMRX / EBS | |
Capitalization | 1.87B | 120M | 1,558% |
EBITDA | 400M | -518.2M | -77% |
Gain YTD | 5.808 | -49.163 | -12% |
P/E Ratio | 90.00 | 17.73 | 508% |
Revenue | 2.39B | 1.02B | 234% |
Total Cash | 91.5M | 112M | 82% |
Total Debt | 2.75B | 860M | 320% |
AMRX | EBS | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 95 Overvalued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 43 | 100 | |
SMR RATING 1..100 | 99 | 97 | |
PRICE GROWTH RATING 1..100 | 47 | 65 | |
P/E GROWTH RATING 1..100 | 22 | 8 | |
SEASONALITY SCORE 1..100 | 4 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EBS's Valuation (56) in the Biotechnology industry is somewhat better than the same rating for AMRX (95) in the Pharmaceuticals Major industry. This means that EBS’s stock grew somewhat faster than AMRX’s over the last 12 months.
AMRX's Profit vs Risk Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for EBS (100) in the Biotechnology industry. This means that AMRX’s stock grew somewhat faster than EBS’s over the last 12 months.
EBS's SMR Rating (97) in the Biotechnology industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that EBS’s stock grew similarly to AMRX’s over the last 12 months.
AMRX's Price Growth Rating (47) in the Pharmaceuticals Major industry is in the same range as EBS (65) in the Biotechnology industry. This means that AMRX’s stock grew similarly to EBS’s over the last 12 months.
EBS's P/E Growth Rating (8) in the Biotechnology industry is in the same range as AMRX (22) in the Pharmaceuticals Major industry. This means that EBS’s stock grew similarly to AMRX’s over the last 12 months.
AMRX | EBS | |
---|---|---|
RSI ODDS (%) | 2 days ago86% | 2 days ago79% |
Stochastic ODDS (%) | 2 days ago88% | 2 days ago75% |
Momentum ODDS (%) | 2 days ago83% | 2 days ago89% |
MACD ODDS (%) | 2 days ago79% | 2 days ago68% |
TrendWeek ODDS (%) | 2 days ago74% | 2 days ago88% |
TrendMonth ODDS (%) | 2 days ago74% | 2 days ago86% |
Advances ODDS (%) | 2 days ago83% | 16 days ago78% |
Declines ODDS (%) | 6 days ago77% | 5 days ago89% |
BollingerBands ODDS (%) | 2 days ago77% | 2 days ago74% |
Aroon ODDS (%) | N/A | 2 days ago86% |